Killer cell immunoglobulin-like receptors on NK cells: The how, where and why

International Journal of Immunogenetics

Volumn 35, Issue 1, 2008, Pages 1-8

  Gardiner, Clair M ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; TRANSCRIPTION FACTOR RUNX3;

ANIMAL CELL; ANTIBODY SPECIFICITY; AUTOIMMUNE DISEASE; CHROMOSOME 19Q; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE REARRANGEMENT; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIGENE FAMILY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PSEUDOGENE; REVIEW; TRANSCRIPTION REGULATION; VIRUS INFECTION;

HLA-B ANTIGENS; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, KIR;

HEPATITIS C VIRUS;

EID: 37848999843     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2007.00739.x     Document Type: Review

References (55)

1. Abi-Rached, L. Parham, P. (2005) Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. Journal of Experimental Medicine, 201, 1319.
2. Alter, G., Martin, M.P., Teigen, N., Carr, W.H., Suscovich, T.J., Schneidewind, A. et al. (2007) Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. Journal of Experimental Medicine, 204, 3027.
3. Anfossi, N., Andre, P., Guia, S., Falk, C.S., Roetynck, S., Stewart, C.A. et al 2006) Human NK cell education by inhibitory receptors for MHC class I. Immunity, 25, 331.
4. Bakker, A.B., Hoek, R.M., Cerwenka, A., Blom, B., Lucian, L., McNeil, T., Murray, R., Phillips, L.H., Sedgwick, J.D. Lanier, L.L. (2000) DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity, 13, 345.
5. Biassoni, R., Pessino, A., Malaspina, A., Cantoni, C., Bottino, C., Sivori, S., Moretta, L. Moretta, A. (1997) Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. European Journal of Immunology, 27, 3095.
6. Bonaparte, M.I. Barker, E. (2004) Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules. Blood, 104, 2087.
7. Carr, W.H., Rosen, D.B., Arase, H., Nixon, D.F., Michaelsson, J. Lanier, L.L. (2007) Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. Journal of Immunology, 178, 647.
8. Carrington, M. Martin, M.P. (2006) The impact of variation at the KIR gene cluster on human disease. Current Topics in Microbiological Immunology, 298, 225.
9. Chan, H.W., Kurago, Z.B., Stewart, C.A., Wilson, M.J., Martin, M.P., Mace, B.E., Carrington, M., Trowsdale, J. Lutz, C.T. (2003) DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. Journal of Experimental Medicine, 197, 245.
10. Cohen, G.B., Gandhi, R.T., Davis, D.M., Mandelboim, O., Chen, B.K., Strominger, J.L. Baltimore, D. (1999) The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity, 10, 661.
11. Davies, G.E., Locke, S.M., Wright, P.W., Li, H., Hanson, R.J., Miller, J.S. Anderson, S.K. (2007) Identification of bidirectional promoters in the human KIR genes. Genes and Immunity, 8, 245.
12. Ensminger, A.W. Chess, A. (2004) Bidirectional promoters regulate the monoallelically expressed Ly49 NK receptors. Immunity, 21, 2.
13. Faure, M. Long, E.O. (2002) KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. Journal of Immunology, 168, 6208.
14. Fernandez, N.C., Treiner, E., Vance, R.E., Jamieson, A.M., Lemieux, S. Raulet, D.H. (2005) A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood, 105, 4416.
15. Gardiner, C.M., Guethlein, L.A., Shilling, H.G., Pando, M., Carr, W.H., Rajalingam, R., Vilches, C. Parham, P. (2001) Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. Journal of Immunology, 166, 2992.
16. Gomez-Lozano, N., de Pablo, R., Puente, S. Vilches, C. (2003) Recognition of HLA-G by the NK cell receptor KIR2DL4 is not essential for human reproduction. European Journal of Immunology, 33, 639.
17. Gomez-Lozano, N., Trompeter, H.I., de Pablo, R., Estefania, E., Uhrberg, M. Vilches, C. (2007) Epigenetic silencing of potentially functional KIR2DL5 alleles: Implications for the acquisition of KIR repertoires by NK cells. European Journal of Immunology, 37, 1954.
18. Gumperz, J.E., Paterson, J.C., Litwin, V., Valiante, N., Lanier, L.L., Parham, P. Little, A.M. (1996) Specificity of two anti-class I HLA monoclonal antibodies that block class I recognition by the NKB1 killer cell inhibitory receptor. Tissue Antigens, 48, 278.
19. Hansasuta, P., Dong, T., Thananchai, H., Weekes, M., Willberg, C., Aldemir, H., Rowland-Jones, S. Braud, V.M. (2004) Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. European Journal of Immunology, 34, 1673.
20. Held, W. Raulet, D.H. (1997) Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. Journal of Experimental Medicine, 185, 2079.
21. Hiby, S.E., Walker, J.J., O'Shaughnessy, K.M., Redman, C.W., Carrington, M., Trowsdale, J. Moffett, A. (2004) Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. Journal of Experimental Medicine, 200, 957.
22. Khakoo, S.I., Thio, C.L., Martin, M.P., Brooks, C.R., Gao, X., Astemborski, J. et al 2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science, 305, 872.
23. Kim, S., Poursine-Laurent, J., Truscott, S.M., Lybarger, L., Song, Y.J., Yang, L. et al 2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature, 436, 709.
24. Liberatore, C., Capanni, M., Albi, N., Volpi, I., Urbani, E., Ruggeri, L., Mencarelli, A., Grignani, F. Velardi, A. (1999) Natural killer cell-mediated lysis of autologous cells modified by gene therapy. Journal of Experimental Medicine, 189, 1855.
25. Martin, M.P., Gao, X., Lee, J.H., Nelson, G.W., Detels, R., Goedert, J.J. et al 2002) Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nature Genetics, 31, 429.
26. Martin, M.P., Qi, Y., Gao, X., Yamada, E., Martin, J.N., Pereyra, F. et al 2007) Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nature Genetics, 39, 733.
27. Mingari, M.C., Vitale, C., Cantoni, C., Bellomo, R., Ponte, M., Schiavetti, F., Bertone, S., Moretta, A. Moretta, L. (1997) Interleukin-15- induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. European Journal of Immunology, 27, 1374.
28. Moretta, L. Moretta, A. (2004) Killer immunoglobulin-like receptors. Current Opinions in Immunology, 16, 626.
29. Moretta, A., Vitale, M., Bottino, C., Orengo, A.M., Morelli, L., Augugliaro, R., Barbaresi, M., Ciccone, E. Moretta, L. (1993) P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. Journal of Experimental Medicine, 178, 597.
30. Nelson, G.W., Martin, M.P., Gladman, D., Wade, J., Trowsdale, J. Carrington, M. (2004) Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. Journal of Immunology, 173, 4273.
31. Norman, P.J., Abi-Rached, L., Gendzekhadze, K., Korbel, D., Gleimer, M., Rowley, D. et al 2007) Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nature Genetics, 39, 1092.
32. O'Connor, G.M., Hart, O.M. Gardiner, C.M. (2006) Putting the natural killer cell in its place. Immunology, 117, 1.
33. O'Connor, G.M., Guinan, K.J., Cunningham, R.T., Middleton, D., Parham, P. Gardiner, C.M. (2007) Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. Journal of Immunology, 178, 235.
34. Olsson, M.Y., Karre, K. Sentman, C.L. (1995) Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand. Proceedings of the National Academy of Sciences USA, 92, 1649.
35. Pando, M.J., Gardiner, C.M., Gleimer, M., McQueen, K.L. Parham, P. (2003) The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. Journal of Immunology, 171, 6640.
36. Parham, P. (2005) MHC class I molecules and KIRs in human history, health and survival. Nature Review of Immunology, 5, 201.
37. Pascal, V., Yamada, E., Martin, M.P., Alter, G., Altfeld, M., Metcalf, J.A. et al 2007) Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection. Journal of Immunology, 179, 1625.
38. Rajagopalan, S. Long, E.O. (1999) A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. Journal of Experimental Medicine, 189, 1093.
39. Rajagopalan, S., Bryceson, Y.T., Kuppusamy, S.P., Geraghty, D.E., Van der Meer, A., Joosten, I. Long, E.O. (2006) Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol, 4, e9.
40. Raulet, D.H. Vance, R.E. (2006) Self-tolerance of natural killer cells. Nature Review of Immunology, 6, 520.
41. Robertson, M.J. Ritz, J. (1990) Biology and clinical relevance of human natural killer cells. Blood, 76, 2421.
42. Santourlidis, S., Trompeter, H.I., Weinhold, S., Eisermann, B., Meyer, K.L., Wernet, P. Uhrberg, M. (2002) Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. Journal of Immunology, 169, 4253.
43. Shilling, H.G., Young, N., Guethlein, L.A., Cheng, N.W., Gardiner, C.M., Tyan, D. Parham, P. (2002) Genetic control of human NK cell repertoire. Journal of Immunology, 169, 239.
44. Single, R.M., Martin, M.P., Gao, X., Meyer, D., Yeager, M., Kidd, J.R., Kidd, K.K. Carrington, M. (2007) Global diversity and evidence for coevolution of KIR and HLA. Nature Genetics, 39 (9), 1114.
45. Stewart, C.A., Van Bergen, J. Trowsdale, J. (2003) Different and divergent regulation of the KIR2DL4 and KIR3DL1 promoters. Journal of Immunology, 170, 6073.
46. Stulberg, M.J., Wright, P.W., Dang, H., Hanson, R.J., Miller, J.S. Anderson, S.K. (2007) Identification of distal KIR promoters and transcripts. Genes Immunity, 8, 124.
47. Trundley, A.E., Hiby, S.E., Chang, C., Sharkey, A.M., Santourlidis, S., Uhrberg, M., Trowsdale, J. Moffett, A. (2006) Molecular characterization of KIR3DL3. Immunogenetics, 57, 904.
48. Uhrberg, M. (2005) Shaping the human NK cell repertoire: an epigenetic glance at KIR gene regulation. Molecular Immunology, 42, 471.
49. Valiante, N.M., Uhrberg, M., Shilling, H.G., Lienert-Weidenbach, K., Arnett, K.L., D'Andrea, A., Phillips, J.H., Lanier, L.L. Parham, P. (1997) Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity, 7, 739.
50. Vilches, C., Gardiner, C.M. Parham, P. (2000) Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene. Journal of Immunology, 165, 6416.
51. Vilches, C. Parham, P. (2002) KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annual Review of Immunology, 20, 217.
52. Winter, C.C., Gumperz, J.E., Parham, P., Long, E.O. Wagtmann, N. (1998) Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. Journal of Immunology, 161, 571.
53. Yawata, M., Yawata, N., Abi-Rached, L. Parham, P. (2002) Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family. Critical Reviews in Immunology, 22, 463.
54. Yawata, M., Yawata, N., Draghi, M., Little, A.M., Partheniou, F. Parham, P. (2006) Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. Journal of Experimental Medicine, 203, 633.
55. Yokoyama, W.M. Kim, S. (2006) Licensing of natural killer cells by self-major histocompatibility complex class I. Immunological Review, 214, 143.